WVU and Pitt team up for laser trial to treat glaucoma
Glaucoma is the leading cause of irreversible blindness in the world. A new study to be conducted by the West Virginia University and the University of Pittsburgh seeks to change that. The National Eye Institute recently awarded the universities $15.2 million to study how a treatment called selective laser trabeculoplasty (SLT) can be better used to treat glaucoma.